Effects of high intensity interval training on sustained reduction in cardiometabolic risk associated with overweight/obesity. A randomized trial.

Cardiometabolic risk Exercise High intensity interval training Long term adherence Moderate intensity continuous training Overweight/obesity

Journal

Journal of exercise science and fitness
ISSN: 1728-869X
Titre abrégé: J Exerc Sci Fit
Pays: Singapore
ID NLM: 101198241

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 29 11 2021
revised: 07 03 2022
accepted: 07 03 2022
entrez: 11 4 2022
pubmed: 12 4 2022
medline: 12 4 2022
Statut: ppublish

Résumé

Considering the potential greater cardiocirculatory effects of high intensity interval training (HIIT), we hypothesized that a 2-month supervised high volume short interval HIIT would induce greater improvements in CRF and cardiometabolic risk and increase long-term maintenance to physical activity compared to isocaloric moderate intensity continuous training (MICT) in overweight/obesity. Sixty (19 females) subjects with overweight/obesity were randomized to three training programs (3 times/week for 2 months): MICT (45 min, 50% peak power output-PPO), HIIT (22 × 1-min cycling at 100% PPO/1-min passive recovery) and HIIT-RM (RM: recovery modulation, i.e. subjects adjusted passive recovery duration between 30s and 2 min). After the intervention, participants no longer benefited from supervised physical activity and were instructed to maintain the same exercise modalities on their own. We assessed anthropometrics, body composition, CRF, fat oxidation, lipid profile, glycemic balance, low-grade inflammation, vascular function, spontaneous physical activity and motivation for eating at three time points: baseline (T0), 4 days after the end of the 2-month supervised training program (T2) and 4 months after the end of the training program (T6). HIIT/HIIT-RM induced greater improvement in VO We have shown greater short-term benefits induced by a high volume short interval (1 min) HIIT on cardiorespiratory fitness and cardiometabolic risk over an isocaloric moderate intensity continuous exercise in persons with overweight/obesity. We also showed greater long-term effects (i.e. after 4 months) of this exercise modality on the maintenance of CRF, decreases in total and abdominal fat masses and total cholesterol/HDL.

Sections du résumé

Background UNASSIGNED
Considering the potential greater cardiocirculatory effects of high intensity interval training (HIIT), we hypothesized that a 2-month supervised high volume short interval HIIT would induce greater improvements in CRF and cardiometabolic risk and increase long-term maintenance to physical activity compared to isocaloric moderate intensity continuous training (MICT) in overweight/obesity.
Methods UNASSIGNED
Sixty (19 females) subjects with overweight/obesity were randomized to three training programs (3 times/week for 2 months): MICT (45 min, 50% peak power output-PPO), HIIT (22 × 1-min cycling at 100% PPO/1-min passive recovery) and HIIT-RM (RM: recovery modulation, i.e. subjects adjusted passive recovery duration between 30s and 2 min). After the intervention, participants no longer benefited from supervised physical activity and were instructed to maintain the same exercise modalities on their own. We assessed anthropometrics, body composition, CRF, fat oxidation, lipid profile, glycemic balance, low-grade inflammation, vascular function, spontaneous physical activity and motivation for eating at three time points: baseline (T0), 4 days after the end of the 2-month supervised training program (T2) and 4 months after the end of the training program (T6).
Results UNASSIGNED
HIIT/HIIT-RM induced greater improvement in VO
Conclusion UNASSIGNED
We have shown greater short-term benefits induced by a high volume short interval (1 min) HIIT on cardiorespiratory fitness and cardiometabolic risk over an isocaloric moderate intensity continuous exercise in persons with overweight/obesity. We also showed greater long-term effects (i.e. after 4 months) of this exercise modality on the maintenance of CRF, decreases in total and abdominal fat masses and total cholesterol/HDL.

Identifiants

pubmed: 35401768
doi: 10.1016/j.jesf.2022.03.001
pii: S1728-869X(22)00017-X
pmc: PMC8956941
doi:

Types de publication

Journal Article

Langues

eng

Pagination

172-181

Informations de copyright

© 2022 The Society of Chinese Scholars on Exercise Physiology and Fitness. Published by Elsevier (Singapore) Pte Ltd.

Déclaration de conflit d'intérêts

The authors report no competing financial interest.

Références

Br J Sports Med. 2017 Mar;51(6):494-503
pubmed: 27797726
Int J Sport Nutr Exerc Metab. 2016 Jun;26(3):197-204
pubmed: 26479856
Eur J Appl Physiol. 2017 Mar;117(3):455-467
pubmed: 28160083
J Physiol. 2017 May 1;595(9):2915-2930
pubmed: 27748956
Ann Behav Med. 2015 Oct;49(5):715-31
pubmed: 25921307
Chest. 2012 Apr;141(4):1031-1039
pubmed: 21940772
Circulation. 2012 Aug 7;126(6):753-67
pubmed: 22869857
Circulation. 2005 Oct 25;112(17):2735-52
pubmed: 16157765
Med Sci Sports Exerc. 2018 Sep;50(9):1818-1826
pubmed: 29683919
JAMA. 2013 Jan 2;309(1):71-82
pubmed: 23280227
Sports Med. 2015 May;45(5):679-92
pubmed: 25771785
Diabetes Metab. 2008 Nov;34(5):514-23
pubmed: 18823806
Am J Physiol Endocrinol Metab. 2006 Jul;291(1):E99-E107
pubmed: 16464906
Circulation. 2007 Jun 19;115(24):3086-94
pubmed: 17548726
Ann Readapt Med Phys. 2007 Jul;50(6):528-34, 520-7
pubmed: 17521770
Med Sci Sports Exerc. 2001 Mar;33(3):413-21
pubmed: 11252068
PLoS One. 2014 Dec 08;9(12):e114541
pubmed: 25486273
J Appl Physiol (1985). 2016 Jul 1;121(1):279-88
pubmed: 27255523
Int J Endocrinol. 2012;2012:983814
pubmed: 22675355
Hypertension. 1995 Sep;26(3):485-90
pubmed: 7649586
Lancet. 2005 Sep 24-30;366(9491):1059-62
pubmed: 16182882
Med Sci Sports Exerc. 2014 Jun;46(6):1159-65
pubmed: 24576863
J Sports Sci. 2011 Mar;29(6):547-53
pubmed: 21360405
Med Sci Sports Exerc. 2010 Oct;42(10):1951-8
pubmed: 20195181
J Strength Cond Res. 2018 Oct;32(10):2730-2742
pubmed: 29746386
Obes Rev. 2016 Apr;17(4):313-29
pubmed: 26806460
J Sports Sci. 2020 Sep;38(17):1997-2004
pubmed: 32497454
Pediatr Obes. 2015 Aug;10(4):311-9
pubmed: 25088157
Med Sci Sports Exerc. 1999 Dec;31(12):1778-87
pubmed: 10613428
Circulation. 2013 Feb 5;127(5):652-62
pubmed: 23295916
Cardiol Rev. 2016 Nov/Dec;24(6):273-281
pubmed: 27548688
Scand J Med Sci Sports. 2014 Apr;24(2):e69-76
pubmed: 24102912
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Diabetes Metab. 2003 Nov;29(5):509-18
pubmed: 14631328
J Magn Reson Imaging. 2011 Oct;34(4):729-749
pubmed: 22025886
Clin Endocrinol (Oxf). 2007 Oct;67(4):582-8
pubmed: 17590171
Clin Sci (Lond). 2008 Nov;115(9):283-93
pubmed: 18338980
Chest. 2005 Jun;127(6):2197-203
pubmed: 15947337
Pediatr Obes. 2016 Feb;11(1):26-32
pubmed: 25727885
Pediatrics. 2005 Jun;115(6):e690-6
pubmed: 15930197
J Investig Med. 2018 Jun;66(5):1-9
pubmed: 29581385
PLoS One. 2019 Jan 28;14(1):e0210644
pubmed: 30689632
J Appl Physiol (1985). 2011 Dec;111(6):1554-60
pubmed: 21868679
Metabolism. 1994 Jul;43(7):814-8
pubmed: 8028502
Eur J Appl Physiol. 2020 Aug;120(8):1787-1803
pubmed: 32514607
Acta Physiol (Oxf). 2012 May;205(1):113-23
pubmed: 21981898
Am J Physiol Regul Integr Comp Physiol. 2008 Jul;295(1):R236-42
pubmed: 18434437
J Physiol. 2012 Mar 1;590(5):1077-84
pubmed: 22289907
Cardiovasc Res. 2007 Sep 1;75(4):690-701
pubmed: 17412312
Eur J Prev Cardiol. 2016 Jan;23(1):14-20
pubmed: 25404752
J Sport Exerc Psychol. 2015 Apr;37(2):138-49
pubmed: 25996105
Med Sci Sports Exerc. 2001 Dec;33(12):2145-56
pubmed: 11740312
Circulation. 2008 Jul 22;118(4):346-54
pubmed: 18606913
J Am Coll Cardiol. 2004 Apr 21;43(8):1399-404
pubmed: 15093874
Exp Physiol. 2014 Jan;99(1):149-63
pubmed: 24036595
J Appl Physiol (1985). 2015 Aug 15;119(4):352-62
pubmed: 26112241
Obes Rev. 2017 Jun;18(6):635-646
pubmed: 28401638
Med Sci Sports Exerc. 2020 Aug;52(8):1641-1649
pubmed: 32102058
JAMA. 2009 May 20;301(19):2024-35
pubmed: 19454641
Respiration. 1999;66(1):25-33
pubmed: 9973687
Int J Behav Nutr Phys Act. 2010 Aug 03;7:60
pubmed: 20682057
Obes Rev. 2016 Aug;17(8):664-90
pubmed: 27213481

Auteurs

Monique Mendelson (M)

Univ. Grenoble Alpes, Inserm, CHU Grenoble Alpes, HP2, 38000, Grenoble, France.

Samarmar Chacaroun (S)

Univ. Grenoble Alpes, Inserm, CHU Grenoble Alpes, HP2, 38000, Grenoble, France.

Sébastien Baillieul (S)

Univ. Grenoble Alpes, Inserm, CHU Grenoble Alpes, HP2, 38000, Grenoble, France.

Stéphane Doutreleau (S)

Univ. Grenoble Alpes, Inserm, CHU Grenoble Alpes, HP2, 38000, Grenoble, France.

Michel Guinot (M)

Univ. Grenoble Alpes, Inserm, CHU Grenoble Alpes, HP2, 38000, Grenoble, France.

Bernard Wuyam (B)

Univ. Grenoble Alpes, Inserm, CHU Grenoble Alpes, HP2, 38000, Grenoble, France.

Renaud Tamisier (R)

Univ. Grenoble Alpes, Inserm, CHU Grenoble Alpes, HP2, 38000, Grenoble, France.

Jean-Louis Pépin (JL)

Univ. Grenoble Alpes, Inserm, CHU Grenoble Alpes, HP2, 38000, Grenoble, France.

François Estève (F)

Inserm - UA07 - Rayonnement Synchrotron pour la Recherche Biomédicale (STROBE) ID17 Installation Européenne du Rayonnement Synchrotron (ESRF), CHU Grenoble Alpes, CLUNI, SCRIMM-Sud, 38000, Grenoble, France.

Damien Tessier (D)

Univ. Grenoble Alpes, Laboratoire SENS, 38000, Grenoble, France.

Samuel Vergès (S)

Univ. Grenoble Alpes, Inserm, CHU Grenoble Alpes, HP2, 38000, Grenoble, France.

Patrice Flore (P)

Univ. Grenoble Alpes, Inserm, CHU Grenoble Alpes, HP2, 38000, Grenoble, France.

Classifications MeSH